Categories: Latest

Shree Pushkar Chemicals & Fertilisers Ltd. IPO Opens on August 25th 2015

Price Band fixed at Rs. 61 to Rs. 65 per Equity Share

  • Promoters of the Company : Mr. Punit Makharia, Mr. Gautam Makharia
  • Issue Opens on : Tuesday, August 25th, 2015
  • Issue Closes on : Thursday, August 27th, 2015
  • Price Band : Rs. 61 to Rs. 65 per Equity Share

Mumbai, Aug 21, 2015: Shree Pushkar Chemicals & Fertilisers Limited, established in 1993 is an ISO 9001:2008 and 14001: 2004 company engaged in the business of manufacturing dye intermediates, acids, fertilizers and cattle feed supplements. Headquartered in Mumbai, it has a state of the art manufacturing facility at Lote Parshuram, Maharashtra, and is a Government of India recognized Export House. The Company has expanded its product range both by way of Backward and Forward Integration in dye intermediates

The Company has emerged as one of the few manufacturers with ‘Zero Waste’ in India.

SPCFL is supported by IFCI Venture Capital Fund which infused growth capital to the extent of Rs. 15.00 crores between 2009-2011.

During 2012, the Company launched its own soil conditioner brand “Dharti Ratna” in Western Maharashtra which has been accepted well in the market.

For the fiscal 2013, 2014 & 2015 the total revenues of the Company stood at are Rs 1765.69 million, Rs 2103.67 million, Rs 2668.14 million with a Profit After Tax (PAT) of Rs. 72.45 million, Rs. 104.35 million and Rs. 186.50 million for the same period.

SPCFL now plans to enter the capital market with initial public offer of its equity shares of face value Rs 10 each for cash aggregating up to Rs. 700 million. Of the total shares offered 2,026,589 shares are on Offer for Sale (OFS).

The Issue opens on Tuesday, August 25, 2015 and closes on Thursday, August 27, 2015 and the Price Band is fixed at Rs. 61/- to Rs. 65/- per equity share.

The price band translates into a Price Earning Multiple (P/E) of 6.77 times at lower end & 7.21 times at upper end of the price band respectively based on Earning Per Share (EPS) for financial year ended March 31, 2015.

The funds raised through fresh issue of equity shares is proposed to be utilized to enhance its existing capacities of H-acid (enhanced capacity : 750 TPA) & Vinyl Sulphone (enhanced capacity : 1000 TPA) and to enter into forward integration by manufacturing reactive dyes (enhanced capacity : 3,000 TPA).

The Issue is being made through the Book Building Process wherein not more than 50% of the Issue shall be Allotted on a proportionate basis to Qualified Institutional Buyers (“QIBs”), 5% of the QIB Portion shall be available for allocation on a proportionate basis to Mutual Funds only, and the remainder of the QIB Portion shall be available for allocation on a proportionate basis to all QIB Bidders, including Mutual Funds, subject to valid Bids being received at or above the Issue Price.

Further, not less than 15% of the Issue shall be available for allocation on a proportionate basis to Non-Institutional Bidders and not less than 35% of the Issue shall be available for allocation to Retail Individual Bidders in accordance with SEBI ICDR Regulations, subject to valid Bids being received at or above the Issue Price.

The equity shares are proposed to be listed on the BSE Limited (“BSE”) and the National Stock Exchange of India Limited (“NSE”).

Keynote Corporate Services Limited is the Book Running Lead Manager to the Issue, and Bigshare Services Private Limited is the Registrar to the issue. CCI Newswire

The Pharma Times News Bureau

Recent Posts

8 Ways Insomnia Affects Skin Health & How To Avoid It

By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…

2 days ago

Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and Treatment

Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…

2 days ago

Healthcare Startups to Watch Out for in 2025

New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…

3 days ago

DKMS’s First Global Impact Report of 2023 Serves as New Ray of Hope for Blood Cancer Patients Worldwide

National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…

3 days ago

Sterling Biotech to start world’s first precision fermentation-based dairy protein factory in Gujarat

Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…

4 days ago

Pioneers in Senior Care, Antara, Partners with Leading Diagnostics Player Dr. Lal PathLabs to Strengthen its Geriatric Care Services

New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…

4 days ago